Neos Therapeutics

  • Adzenys XR 2021 report

    Adzenys XR 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 26 Pages The 5 Key Questions Addressed by this...

  • Cotempla XR-ODT 2021 report

    Cotempla XR-ODT 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 27 Pages The 5 Key Questions Addressed by this...

  • Karbinal ER 2021 report

    Karbinal ER 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 29 Pages The 5 Key Questions Addressed by this...

  • Zolpimist 2021 report

    Zolpimist 2021 U.S. PROMOTIONAL AUDIT REPORT Published July 2022 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Adzenys XR 2019 report

    Adzenys XR 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 21 Pages The 5 Key Questions Addressed by this...

  • Cotempla XR-ODT 2019 report

    Cotempla XR-ODT 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 21 Pages The 5 Key Questions Addressed by this...

  • Adzenys XR 2018 report

    Adzenys XR 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 24 Pages The 5 Key Questions Addressed by this...

  • Cotempla XR-ODT 2018 report

    Cotempla XR-ODT 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 21 Pages The 5 Key Questions Addressed by this...

  • Adzenys XR 2017 report

    Adzenys XR 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 24 Pages The 5 Key Questions Addressed by this...

  • Adzenys XR 2016 report

    Adzenys XR 2016 U.S. PROMOTIONAL AUDIT REPORT Published July 2017 • 21 Pages The 5 Key Questions Addressed by this...